Literature DB >> 3202522

The effect of bacterial products on ciliary function.

R Wilson1, P J Cole.   

Abstract

Mucociliary clearance protects the respiratory epithelium against inhaled particles. There is in vitro evidence that some bacteria produce factors that cause ciliary slowing, dyskinesia, and stasis. These changes may predominantly affect ciliary function alone or be associated with epithelial disruption and cell death. Some factors act immediately, while others can take up to a number of days to achieve effect. It is postulated that rapidly acting factors may be involved during bacterial colonization, allowing the bacterium time (by slowing clearance) to penetrate the mucociliary barrier and reach putative receptors on the epithelial surface. The compounds might similarly facilitate contiguous spread through the bronchial tree and augment the tissue damage caused by the host inflammatory response during chronic bronchial sepsis. Future work should define more clearly the in vivo significance of the largely in vitro observations made to date.

Entities:  

Mesh:

Year:  1988        PMID: 3202522     DOI: 10.1164/ajrccm/138.6_Pt_2.S49

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

Review 1.  Pulmonary disposition of antimicrobial agents: methodological considerations.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

2.  Sialidase-based anti-influenza virus therapy protects against secondary pneumococcal infection.

Authors:  Maria Hedlund; Laura M Aschenbrenner; Kellie Jensen; Jeffrey L Larson; Fang Fang
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

3.  Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner.

Authors:  Vasanthi Avadhanula; Carina A Rodriguez; John P Devincenzo; Yan Wang; Richard J Webby; Glen C Ulett; Elisabeth E Adderson
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 4.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

5.  Could vitamin d have a potential anti-inflammatory and anti-infective role in bronchiectasis?

Authors:  Jim Bartley; Jeff Garrett; Cameron C Grant; Carlos A Camargo
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

6.  A novel Filobacterium sp can cause chronic bronchitis in cats.

Authors:  Martina Načeradská; Sona Pekova; Patrizia Danesi; Tommaso Furlanello; Roberta Calleo; Patricia Martin; Fumio Ike; Richard Malik
Journal:  PLoS One       Date:  2021-06-09       Impact factor: 3.240

Review 7.  The pathophysiology of bronchiectasis.

Authors:  Paul T King
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-11-29

8.  Addition of hyaluronic acid improves tolerance to 7% hypertonic saline solution in bronchiectasis patients.

Authors:  Luis Máiz; Rosa M Girón; Eva Prats; Marta G Clemente; Eva Polverino; Silvia Caño; Rosa Cordovilla; Jordi Dorca; Carlos Peñalver; Félix Baranda; Miguel A Martínez-García
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

9.  Clinical Aspects of Upper and Lower Respiratory Tract Infections.

Authors:  Ronald F Grossman
Journal:  Drug Investig       Date:  2012-10-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.